8-A12B

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

SEC Filing Details

Document Details

Filing Date
Jan 5, 2021
Document Date
Jan 5, 2021
Form Description
Registration of certain classes of securities 12(b) of the Securities Exchange Act
Filing Group
Registration Statements
Company
KemPharm
Issuer
KEMPHARM, INC